Normal view MARC view

Building strong condition brands

Author: Angelmar, Reinhard ; Angelmar, Sarah ; Kane, LizINSEAD Area: MarketingIn: Journal of Medical Marketing, vol. 7, no. 4, August 2007 Language: EnglishDescription: p. 341-351.Type of document: INSEAD ArticleNote: Please ask us for this itemAbstract: With blockbuster brands such as Pfizer's Lipitor, GlaxoSmithKline's Advair, AstraZeneca's Nexium and many others, the pharmaceutical industry has demonstrated its expertise in building strong product brands. However, product branding focused marketing leaves many patients untreated. Patients who do not recognize particular symptoms and medical conditions are less likely to seek medical attention and treatment, and their family doctor lacks the time to probe for each and every possible medical condition. Product branding tells consumers about a solution but not about the problem which the solution addresses. Condition branding educates consumers, physicians and other stakeholders about the problem. We propose that the pharmaceutical marketing paradigm be broadened. Pharmaceutical marketers should build strong condition brands, much as they build strong product brands. Condition branding facilitates customers' decision-making, contributes to better health, and may improve the standing of the pharmaceutical industry, which is accused of overly aggressive product branding efforts, among other criticisms. When condition and product branding are well-coordinated, each enhances the effectiveness of the other, raising patient health and brand sales
Tags: No tags from this library for this title. Log in to add tags.
Item type Current location Call number Status Date due Barcode Item holds
INSEAD Article Europe Campus
Available BC008368
Total holds: 0

Ask Qualtrics

With blockbuster brands such as Pfizer's Lipitor, GlaxoSmithKline's Advair, AstraZeneca's Nexium and many others, the pharmaceutical industry has demonstrated its expertise in building strong product brands. However, product branding focused marketing leaves many patients untreated. Patients who do not recognize particular symptoms and medical conditions are less likely to seek medical attention and treatment, and their family doctor lacks the time to probe for each and every possible medical condition. Product branding tells consumers about a solution but not about the problem which the solution addresses. Condition branding educates consumers, physicians and other stakeholders about the problem. We propose that the pharmaceutical marketing paradigm be broadened. Pharmaceutical marketers should build strong condition brands, much as they build strong product brands. Condition branding facilitates customers' decision-making, contributes to better health, and may improve the standing of the pharmaceutical industry, which is accused of overly aggressive product branding efforts, among other criticisms. When condition and product branding are well-coordinated, each enhances the effectiveness of the other, raising patient health and brand sales

Digitized

There are no comments for this item.

Log in to your account to post a comment.
Koha 18.11 - INSEAD Catalogue
Home | Contact Us | What's Koha?